[Recurring corneal lesions during cholesterol synthesis enzyme inhibitor administration?].
Behrens-Baumann
W
W
Augenklinik, Otto-von-Guericke-Universität, Leipziger Strasse, Magdeburg, Germany.
D000924:Anticholesteremic Agents / Q000009:adverse effects*; D065306:Corneal Injuries; D005131:Eye Injuries / Q000139:chemically induced*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects*; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy*; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy*; D012008:Recurrence
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors